Delivery Order SPE2DB20D1100-SPE2DB25FD5H6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 100 mg capsules in a 60-count configuration. This competitive delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price pharmaceutical procurement to support federal medical supply needs. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors....
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $8,590.58 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which has an ultimate completion date of January 24, 2025, is for the supply of OFEV 150 MG CAPSULE 60S medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a $7,643.51 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg capsules of OFEV to treat idiopathic pulmonary fibrosis. Amerisourcebergen will deliver 60 capsules to a facility in Conshohocken, Pennsylvania under a contract starting on September 21, 2023 and ending on October 13, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for OFEV capsules supports the DLA's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a ceiling value of $7,905.56. The contract has an ultimate completion date of April 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OFEV 100 MG Capsules 60s, a pharmaceutical product, at a firm fixed price of $8,630.28. The contract has an ultimate completion date of July 15, 2025. This appears to be a non-set-aside contract, meaning it was open to full and open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,630.28, is for the delivery of OFEV 100 MG CAPSULE 60S, a pharmaceutical product, with a performance period ending on May 6, 2025. The contract is a firm fixed-price delivery order and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $8,590.58 and an ultimate completion date of August 8, 2025. The contract was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply OFEV 150 MG capsules in 60-count packages. The contract has a ceiling value of $7,905.56 and a performance period through April 17, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply OFEV 150 MG capsules for a total ceiling value of $7,905.56. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,811.12 firm fixed-price contract is for the delivery of OFEV 150 MG capsules. The contract has an ultimate completion date of November 29, 2024 and was awarded on November 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD5H6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with this contract supporting the Defense Logistics Agency's Medical Supply Chain. OFEV is an FDA-approved pulmonary fibrosis medication, and this order fulfills medical supply needs for military and veteran healthcare systems. The underlying IDC vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical commodities globally to support military healthcare programs, including support for the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 7/18/25 |